An FDA committee voted in favor of approving a treatment for peanut allergies in children. If the full FDA votes for it, it would be the first FDA-approved treatment for peanut allergy.
The drug Palforzia is designed to minimize the incidence and severity of allergic reactions in people from ages 4 to 17 with peanut allergies. While the advisory committee has voted in favor of the treatment, the FDA will make its final approval by January. The agency frequently follows the lead of the advisory committee. If approved, this will become the first FDA approved treatment for peanut allergy.
A phase 3 trial submitted as evidence in favor of the drug by the manufacturers found that 2/3 of children were able to eat the equivalent of 2 peanuts without any allergic symptoms after the course of treatment. Patients may be required to take the therapy for six months or longer. The company said the most common adverse effects were abdominal discomfort or pain, coughing, hives, itching, nausea, throat irritation and vomiting.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Juul says it will keep running 'Make the Switch' ad campaign despite FDA concernsThe FDA sent Juul a warning letter this week about its campaign urging people to 'Make the Switch' from cigarettes, but the company isn't backing down.
Consulte Mais informação »
Column: A stem cell clinic under fire by the FDA and ex-patients files for bankruptcyA La Jolla clinic pitching $15,000 stem cell treatments files for bankruptcy, facing a lawsuit from former patients.
Consulte Mais informação »
FDA finds impurity in popular heartburn medicine Zantac that could cause cancerThe FDA has learned that Sanofi's heartburn medication Zantac carries a substance that could cause cancer.
Consulte Mais informação »
GE Healthcare earned FDA clearance for its AI-powered portable x-rayGE Healthcare earned the FDA's approval for its AI-powered mobile X-ray device – marking the first time the FDA has cleared a tool of its kind.
Consulte Mais informação »
FDA advisory committee to vote on peanut allergy treatmentAn advisory committee for the FDA will vote today on whether to recommend a peanut allergy treatment for FDA approval.
Consulte Mais informação »